Curation FAME2 STARD7
12 + 0 = 12 / 18
Genetic evidence
Total: 12
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | Twenty-two FAME2 pedigrees were investigated; 158 affected individuals tested positive for the intronic STARD7 ATTTC expansion by RP-PCR, including 137/137 affected individuals from 16 previously reported chromosome 2-linked families and 20/20 familial clinically similar cases. | |
Collective Evidence | Allele | 1 | Long-read sequencing resolved expanded STARD7 repeat structures in affected individuals, including combined AAATG/AAAAT insertions of ~3.3–4.6 kb, and Family 1 showed anticipation with median onset decreasing from generation III (30 years) to IV (17 years) to V (12 years). | |
Collective Evidence | Computational | 0.5 | Short-read WGS analysis with ExpansionHunter and exSTRa identified ATTTT/ATTTC repeat expansions in the FAME2 interval in affected samples; all FAME2 carriers were significant exSTRa outliers at the FAME2-AAATG locus (p < 0.0001) compared with 69 unaffected WGS controls. | |
Collective Evidence | Segregation | 1.5 | RP-PCR showed the STARD7 ATTTC expansion segregated with FAME in 158/158 affected individuals across 22 families; 24 unaffected relatives were negative, and two expansion-positive individuals without a FAME diagnosis were from younger generations and considered likely presymptomatic. | |
Statistics | Case-control data | 6 | The ATTTC repeat was absent from WGS data for 69 controls and did not amplify in 28 unaffected unrelated control DNA samples; among family testing, 158 affected individuals were expansion-positive and no affected individuals were expansion-negative. |
Experimental evidence
Total: 0
No experimental evidence details available.